8 бет - Ең жақсы онкологияның онкологтар - ЖОҒ-653 дәрігерлер

Dr. Francesc Graus is a neurologist with expertise in paraneoplastic neurological syndromes, gliomas, and primary brain lymphomas. He established the first strict diagnostic criteria for paraneoplastic syndromes. He also identified important antibodies that are now used in diagnosis. His research showed the link between tumors and autoimmune neurological attacks.

Dr. Graus earned his MD and PhD from Universitat Autònoma de Barcelona. He completed his neurology residency in Barcelona and a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center. He is an Emeritus investigator at IDIBAPS. He founded and served as president of the European Association of Neuro-Oncology. He is also the former chief of neurology at Hospital Clinic Barcelona.

2023 – Istanbul Gaziosmanpaşa Taksim Education and Research Hospital – General Surgery Clinic Associate Professor

2013 – Istanbul Gaziosmanpaşa Taksim Education and Research Hospital – General Surgery Clinic Specialist

2008 – 2013 Private Medical Park Fatih Hospital, General Surgery Specialist - Deputy Chief Physician

2005 – 2007 Private Gelişim Hospital – General Surgery Specialist

2003 – 2005 Private Istanbul Şafak Hospital – General Surgery Specialist - Chief Physician

2002 – 2003 ISTANBUL HASEKİ EDUCATION AND RESEARCH HOSPITAL – General Surgery Clinic Assistant Physician

1998 – 2002 Ankara Education and Research Hospital – General Surgery Clinic Assistant Physician

1998 – Health Sciences University – Istanbul Haseki Health Application and Research Center – Medical Specialization

1991 – Gazi University Faculty of Medicine – Bachelor’s Degree

Certificates

IGM Diagnosis, Treatment Workshop, Granulomatous Mastitis, Kocaeli, Certificate, 07.10.2023 (National)

ibreast 51- Free Flap Reconstruction, Breast Cancer Surgery, Online, Certificate, 30.09.2023 – 30.09.2023 (International)

ibreast 50- Triple Negative Breast Cancer, Breast Cancer, Online, Certificate, 02.09.2023 -02.09.2023 (International)

ibreast 49- Implant Based Reconstruction, Breast Cancer, Online, Certificate, 12.08.2023 -12.08.2023 (International)

ibreast 48- DCIS, İbreast 48- DCIS, Online, Certificate, 15.07.2023 -15.07.2023 (International)

ibreast 47- Conference Updates, Breast Cancer, Online, Certificate, 25.06.2023 -25.06.2023 (International)

ibreast 46- Margin Revisited, Breast Cancer, Online, Certificate, 10.06.2023 -10.06.2023 (International)

1. International 4. National Breast Surgery Congress, Breast Surgery, Ürgüp, Certificate, 05.05.2023 – 07.05.2023 (International)

ibreast 44- HER2 Positive Disease, Breast Cancer, Online, Certificate, 29.04.2023 -29.04.2023 (International)

St-Gallen 2023, St-Gallen Congress Summary Meeting, Istanbul, Certificate, 01.04.2023 -01.04.2023 (National)

ibreast 43- Save The Nipple, Breast Cancer, Online, Certificate, 25.03.2023 -25.03.2023 (International)

ibreast 42-Chest Wall Perforator Flap Revisited, Breast Cancer, Online, Certificate, 25.02.2023 -25.02.2023 (International)

ibreast 41- High Risk And B3 Lesions, Breast Diseases, Online, Certificate, 28.01.2023 -28.01.2023 (International)

15. New Approaches in Breast Cancer Education Meeting, Breast Cancer, Istanbul, Certificate, 07.01.2023 – 08.01.2023 (National)

Articles she wrote and took part in;

1.YILDIRIM EMİNE, BEKTAŞ SİBEL, YETİŞ FIRAT, YILDIZ EREN OZAN, ÖZDEMİR MUHAMMED, KOMUT NESLİHAN, ÇALIK MUSTAFA, ER AHMET MUZAFFER. Correlation between breast and axillary pathologic complete response after neoadjuvant chemotherapy in breast cancer. Annali Italiani di Chirurgia, 2023

2.UZUN NEDİM, YILDIRIM EMİNE. Relationship Between Toilet Type and Hemorrhoids. Bezmialem Vakif University, 2022

3.YILDIZ EREN OZAN, YILDIRIM EMİNE, ORHUN ERDOĞAN KIVILCIM, ERYILMAZ İKLİL, YÜNLÜEL EMİR MEHMET, YETİŞ FIRAT, ULUKENT SUAT CAN. The effect of the covid 19 pandemic on the number of patients treated for acute and complex acute appendicitis. Annali Italiani di Chirurgia, 2202

4.YILDIRIM EMİNE, BEKTAŞ SİBEL, ÖZDEMİR MUHAMMED, KARAGÜLLE AHENK, ER AHMET MUZAFFER, UÇAR NEŞE. Upgrade Rates of DCIS, Intraductal Papilloma, and the Other High-risk Breast Lesions. Hamidiye Medical Journal, 2022
 

5.ÖZKAN GÜMÜŞKAYA PERİHAN, ALTUN ÖZGÜR, KARAKÜTÜK YÜZTAŞ NUR, ÖZSOY NESLİHAN, AYDIN TUTAK GÜLTEN, YILDIRIM EMİNE, ADAŞ MİNE, KÜÇÜK MEHMET. COVID-19 Pnömonisi Sonrası AntiHBs Değerlerindeki Değişiklikler. Journal of Contemporary Medicine, 2022;12(4), 

6.KOMUT NESLİHAN, BEKTAŞ SİBEL, YILDIRIM EMİNE. The relationship of tumor budding with GOLPH3 expression and histopathological prognostic parameters in colorectal adenocarcinoma. Annals of Diagnostic Pathology 2022 Jun;58:151933. 

7.KAYADİBİ YASEMİN, UÇAR NEŞE, AKAN YEŞİM NAMDAR, KAYA MEHMET FATİH, YILDIRIM EMİNE, ALADAĞ KURT SEDA, SOYLU BOY FATMA NUR, TAŞKIN FÜSUN, İÇTEN GÜL ESEN. Magnetic resonance imaging findings associated with recurrence in idiopathic granulomatous mastitis. Clinical Imaging, 2022

8.YILDIRIM EMİNE, KEĞİN MURAT, ÖZDEMİR MUHAMMED, BEKTAŞ SİBEL, PELEN ZEKERİYA, ER AHMET MUZAFFER. Neoplasms of theAppendix; Single Institution and Ten-Year Experiences Results. Turkish Journal of Trauma and Emergency Surgery, 2022;28(3), 352-360

9.YILDIRIM EMİNE, YILDIZ EREN OZAN, ERYILMAZ İKLİL, ER AHMET MUZAFFER, BEKTAŞ SİBEL. Comparison of excised breast volume, re-excision rate and margin positivity in breast-conserving surgery in breast cancer patients using and not using neoadjuvant chemotherapy. Journal of Surgery in Medicine,2022;6

10.YILDIRIM EMİNE, BEKTAŞ SİBEL, PELEN ZEKERİYA, YANIK İREM, ER AHMET MUZAFFER, ÇENGEL FERHAT, ÖZKAN GÜMÜŞKAYA PERİHAN. Histopathological, Radiological, and Demographic Factors Predicting the Response to Neoadjuvant Therapy for Rectal Cancer. Journal of Gastrointestinal Cancer, 2022;53(1)

11.KAYADİBİ YASEMİN, KOÇAK BURAK, UÇAR NEŞE, AKAN YEŞİM NAMDAR, YILDIRIM EMİNE, BEKTAŞ SİBEL. MRI Radiomics of Breast Cancer: Machine Learning-Based Prediction of Lymphovascular Invasion Status. Academic Radiology, 2022;29(1), 126-134.

12.YILDIRIM EMİNE, UÇAR NEŞE, YETİŞ FIRAT, KAYADİBİ YASEMİN, BEKTAŞ SİBEL. Diagnostic performance of breast imaging with ultrasonography, magnetic resonance and mammography in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients. Journal of Surgery and Medicine, 2022;6(1), 43-48

13.YILDIRIM EMİNE, BEKTAŞ SİBEL, GÖKTAŞ AYDIN SABİN, ER AHMET MUZAFFER, YANIK İREM, ÖZKAN GÜMÜŞKAYA PERİHAN, YILMAZ BARBAROS UTKU, BİLİCİ AHMET, ÖNCEL MUSTAFA. Factors Predicting Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, 2022;85(1), 41-50. 

14.YILDIRIM EMİNE, Pelen Zekeriya, KEĞİN MURAT, UÇAR NEŞE, KAYADİBİ YASEMİN, GÜNDOĞAR ÖZGECAN. Evaluation of the Reliability of Preoperative Ultrasonography and Ultrasonography-Guided Fine Needle Aspiration Biopsy in Axillary Staging in Patients With Breast Cancer. Journal of Academic Research in Medicine, 2021;11(3), 269-276., 

15. KAYADİBİ YASEMİN, UÇAR NEŞE, KAYA MEHMET FATİH, YILDIRIM EMİNE, BEKTAŞ SİBEL. Characterization of Suspicious Microcalcifications on Mammography Using 2D Shear-Wave Elastography. Ultrasound in Medicine & Biology, 2022;47(9), 2532-2542. 

16.KAYADİBİ YASEMİN, TEKCAN ŞANLI DENİZ ESİN, UÇAR NEŞE, YILDIRIM EMİNE, ŞANLI AHMET NECATİ. Evaluation of the Appearance Characteristics of Suspicious Microcalcifications Detected by Ultrasonography. Journal of Academic Research in Medicine, 2022;11(2), 199-205. 

17.YILDIRIM EMİNE, ÖZER HİLAL, ÖZER İLTER, KOYUNCU ADİL, YILDIRIM TİMUR. The Effects on Bacterial Translocation and Tissue Damage of Selenium Treatment in an Experimental Intestinal Ischaemia-Reperfusion Model. Turkish Journal of Trauma and Emergency Surgery, 2021;27(4), 389-394. 

18.YILDIRIM EMİNE, AKBAŞ PELİN, ORHUN ERDOĞAN KIVILCIM, BEKTAŞ SİBEL, ÖZKAN GÜMÜŞKAYA PERİHAN, ER AHMET MUZAFFER, PALTURA CEKİ. The comparison of the histopathological results of the thyroid fine-needle aspiration biopsies in the 795 patients with thyroidectomy. Diagnostic Cytopathology, 2021

Professor Nadia Di Muzio is a Head of the Radiotherapy Department in the San Raffaele Research Hospital in Milan since 2008. She has a degree in general medicine and surgery and specialty in oncological radiotherapy from the University of Milan and has done an internship at the Department of Radiation Oncology in the University of Madison. Professor Di Muzio is an author of 200 studies in radiation oncology research and an advocate of high-precision hypofraction methods in the radical treatment of prostate tumors. She currently holds positions in the Italian Association of Medical Oncology, the Italian Society of Oncological Urology and the European Society for Radiotherapy and Oncology.

• Education: 
•  
• 2001-2007: University of Ioannina Medical School, Greece.
• 2007: Degree in Medicine.
• 2013: Doctoral degree from the Medical School of the Johann Wolfgang Goethe University, Frankfurt (Dr. Med)
• 09.2016 – Today: Master’s in Healthcare Business Studies.

Professional experience:

04.2009 – 04.2013: Resident in the Department for Radiation Oncology, Klinikum Offenbach

05.2013 – 12. 2015: Senior physician in the Department for Radiation Oncology, Klinikum Offenbach

• 01.2016 – 06.2017: Senior physician in the Department of interventional Radiation Oncology, Medical Center Athens
•  
• 07.2017 – Today: Head of the Department of Radiation Oncology at the German Oncology Center, Limassol, Cyprus.

Senior surgeon of the “Gastrointestinal Medicine: General and Abdominal Surgery – Gastroenterology and Endoscopy” Department

Education

09 / 2004 – 07 / 2006                Movie Director School, ANT1 Movie School Athens, Greece, Degree “Television Director”, grade point average: B

09 / 2006 – 08 / 2008                Medical School, Semmelweis University Budapest, Hungary, Medical preliminary examination (Physikum), grade point average: A

10 / 2008 – 05 / 2013                Medical School, Albert-Ludwigs-Universität Freiburg, Germany, State examination in medicine, grade point average: A

02/ 2009 – 02/2012                   Institute of Pharamcology and Toxicology I, Albert-Ludwigs-Universität Freiburg, Germany, Doctoral thesis, grade: summa cum laude

05 / 2018                                      Basic and advanced course in German drug law and GCP, Clinical Trials Unit, Medical Center - University of Freiburg

01 / 2019                                      Board certification: Radiotherapy and Radiation Oncology

03 / 2020                                      Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Habilitation (Postdoctoral lecture qualification)

09 / 21 – 08 / 23                         MHBA, Friedrich Alexander University, Nuernberg, Germany

07 / 2022                                      Completion of ISO 9001:2015 training, Nicosia, Cyprus

Professional Career

09 / 2013 – 01 / 2019               Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Residency                                                

07 / 2017 – 07 / 2020               Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Clinician Scientist

Since 06 / 2019                          Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Consultant

01 / 2021 – 12 / 2022                Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Advanced Clinician Scientist

01 / 2021 – 12 / 2021                 Head of the section “Interventional Radiation Oncology”, Medical Center University of Freiburg, Department of Radiation Oncology, Germany

Since 01 / 2022                         Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Prostate cancer research group leader

Since 01 / 2022                          German Medical Institute, Limassol, Cyprus, Vice Medical Director

Professional Memberships and Distinctions

2010           Sanofi-Aventis poster prize, Annual meeting of the German Society of Pharmacology and Toxicology 2010, Mainz, Germany      

2017           Poster prize, Annual meeting of the German Society of Radiation Oncology (DEGRO) 2017, Berlin, Germany

2019           Poster prize, Uro-Oncological Symposium 2019, Magdeburg, Germany

2020           Invited member of the German expert panel for prostate cancer of the German Society of Radiation Oncology (DEGRO)

2020           Herman-Holthusen Award, German Society of Radiation Oncology (DEGRO)

2021           Invited member of the ESTRO-ACROP guideline committee for prostate cancer

2021           Best Abstract, EMUC congress 2021, Athens, Greece

2023           Annual ARO study price for the HypoFocal-SBRT study from the German Cancer Foundation

2023           Invited member of the ESTRO focus group “Urology”

EXPERIENCE

2024 - Present, Istanbul/Turkey

MEMORIAL ŞİŞLİ HOSPITAL

Internal Medicine and Medical Oncology Specialist

2021 - 2024, Istanbul/Turkey

NEW CENTURY UNIVERSITY PRIVATE GOP HOSPITAL

Assistant Professor of Medical Oncology

2017 - 2021, Istanbul/Turkey

ŞİŞLİ ETFAL EDUCATION AND RESEARCH HOSPITAL

Medical Oncology Specialist

2010 - 2014, Malatya/Turkey

DOĞANŞEHİR STATE HOSPITAL

Internal Medicine Specialist

EDUCATION
 

2014 - 2017, Malatya/Turkey

Inönü University Faculty of Medicine

Medical Oncology Subspecialty Training

2005 - 2010, Samsun/Turkey

Ondokuz Mayıs University Faculty of Medicine

Internal Medicine Residency

1998 - 2005, Kayseri/Turkey

Erciyes University Faculty of Medicine

Medical Doctor Education

2021 - Currently, İstanbul

ASSOCIATE PROFESSOR

ASSOCIATE PROFESSOR

2009 - 2012, İstanbul / Turkey

T.R. ISTANBUL SCIENCE UNIVERSITY EUROPEAN FLORENCE NIGHTINGALE HOSPITAL

Minor Specialization Training

2003 - 2008, İstanbul / Turkey

ŞİŞLİ HAMİDİYE ETFAL EDUCATION AND RESEARCH HOSPITAL

Assistant Physician

1990 - 1996, Ankara / Turkey

GAZİ UNIVERSITY FACULTY OF MEDICINE

Medical Doctor Training

Dr. Pimchaya Panichkul is a licensed physician since 2002. Her training includes dermatology, surgery, anti-aging medicine, and facial plastic procedures.

Credentials: Doctor of Medicine (Rangsit University). Diploma in Dermatology and Surgery (USA). Certificate in Anti-aging Medicine. Certificate in Facial Plastic Surgery (Korea). Professional membership: Panasia Cosmetic.

Dr. Keerapat Phiromkraiphakdi is an expert plastic surgeon and consultant at the Center for Aesthetic Plastic Surgery. He specializes in plastic surgery. His core expertise is cosmetic surgery.

He earned degrees in general surgery and plastic surgery from Vajira Hospital and Ramathibodi Hospital. He also completed advanced plastic surgery training in the United States at UTHSC, PACES Plastic Surgery, and UMC.

He is a medical professor at Srinakharinwirot University and the Panyananda Bhikkhu Medical Center, Irrigation Department. He is a member of the Thai Society of Plastic Surgeons.

Dr. Sema Karakas specializes in gynecologic oncology surgery. She also performs minimally invasive gynecologic surgery, including laparoscopy and V-NOTES (scarless) techniques.

She offers V-NOTES hysterectomy and cyst removal. She performs surgery for uterine cancer and tubal ligation. She provides a full range of laparoscopic gynecologic procedures. She treats urinary incontinence with medical, laser, or surgical options and pelvic floor physiotherapy. She manages HPV with diagnosis, treatment, and follow-up. She performs colposcopy, LEEP, and conization. She provides endometriosis care and surgery. She treats polyps and uterine septum with hysteroscopy. She offers perimenopausal and menopausal care and bioidentical hormone therapy.

Professor of Oncology and Hematology

Dr. Rashad Rzazade is a skilled radiation oncologist. He specializes in advanced cancer treatments, including IMRT, SRT, proton therapy, and CyberKnife. He has strong experience treating head and neck cancers, brain tumors, lung, spine, cervical, and gastrointestinal cancers.

Dr. Rzazade trained at Azerbaijan Medical School, Hacettepe University, and Marmara University. He also gained international experience at MD Anderson Cancer Center. He has treated thousands of patients and is known for high survival rates and patient satisfaction in complex cancer cases.

Endocrinologist

Профессор Ари Рафаэль — Translational Oncology трансляциялық онкология қызметінің директоры және Тель-Авивтегі Сураски медициналық орталығының (Ихилов, Тель-Авив) қатерлі ісікке арналған клиникалық зерттеулер бөлімінің ғылыми қызметкері. Науқастар оның жеке көзқарасын және әр адамның қажеттіліктеріне деген назарын жоғары бағалайды.

Құзыреті және пациенттер үшін маңыздылығы:

• Күндізгі онкологиялық аурухана бөлімін басқарады және ұлттық геномдық медицина жобаларын басқарады. Бұл арқылы озық зерттеулерге қолжетімділікті қамтамасыз етеді.

• I–III фазалы көптеген клиникалық сынақтарда жетекші қосымша зерттеуші және бас зерттеуші болған, оның ішінде ісік ішілік мРНҚ инъекциялары және вирус препараттары бар. Науқастар инновациялық емдеу әдістеріне қатысады.

• АҚШ және Ұлыбританияда халықаралық тәжірибесі бар — әлемдік стандарттар мен озық протоколдарды қолдануды қамтамасыз етеді.

• Халықаралық ұйымдардың мүшесі (ESMO, IASLC, ISLB, ISCORT, Israeli Medical Association). Қазіргі заманғы емдеу стандарттарын қолданады және әлемдік зерттеулерге қатысады.

•  Үнемі біліктілігін көтеріп, халықаралық клиникалық практика стандарттарына сәйкес оқудан өтеді, оның ішінде ICH GCP R2, Israeli MOH Guidelines, сондай-ақ ақпараттандырылған келісім, жанама әсерлерді басқару және науқастардың қауіпсіздігі бойынша жаңартылған курстар бар.

Пациенттер профессор Рафаэльді емдеу жоспарларын дәл таңдағаны, инновацияларды енгізгені және мұқият қатынасы үшін жоғары бағалайды, бұл терапияның барлық кезеңдерінде сенімділік пен қауіпсіздікті қамтамасыз етеді.

Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.

Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.